John Devine
Partner

Overview
John Devine is a corporate services and mergers and acquisitions (M&A) attorney in Holland & Knight's Philadelphia office. Mr. Devine focuses his practice on private M&A transactions, including private equity and venture capital financing transactions, securities offerings and commercial licensing transactions, with concentrated experience in the healthcare industry.
Mr. Devine's transactional experience spans a variety of industries, including healthcare, pharmaceuticals, life sciences, light manufacturing, consumer products, consulting services, and food and beverage. Since 2008, he has advised on regulatory and strategic transaction matters to healthcare industry clients, including hospitals, health systems, physician group practices and home health providers.
Previously, Mr. Devine served as chief legal officer of a healthcare startup focused on providing pharmaceutical services to patients in the Southeast. His transactional experience enables him to provide practical and creative business solutions to clients in the healthcare industry and beyond. He also speaks regularly on healthcare transactional and regulatory matters locally and nationally.
Prior to joining Holland & Knight, Mr. Devine was a corporate transactional attorney for a national law firm in its Philadelphia office.
In the community, Mr. Devine devotes substantial time to serving on boards that promote community and culture in Philadelphia and surrounding neighborhoods.
Representative Experience
Credentials
- Villanova University Charles Widger School of Law, J.D.
- Brown University, B.A.
- Pennsylvania
- Philadelphia Bar Foundation, Board of Trustees, 2023-Present
- Mann Music Center for the Performing Arts, Council Member, 2018-Present
- Chestnut Hill Community Fund, Board Member, 2018-2021
- Ernst & Young Entrepreneur of the Year Program, Candidate Selection Committee, 2011-2014, 2015-Present
- Bringing Hope Home Inc., Pro Bono Legal Counsel, 2008-2014
- Chambers USA – America's Leading Business Lawyers guide, Healthcare, 2023-2024